Lysophosphatidylcholine-Docosahexaenoic acid (LPC-DHA), a novel nutraceutical for the prevention of blindness associated with Alzheimer's Disease

被引:0
|
作者
Dhavamani, Sugasini [1 ]
Dhavamani, Sugasini [1 ]
机构
[1] Univ Illinois, Chicago, IL USA
关键词
D O I
10.1016/j.jbc.2023.104346
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1692
引用
收藏
页码:S736 / S736
页数:1
相关论文
共 12 条
  • [1] DOCOSAHEXAENOIC ACID (DHA): A NUTRITIONAL VIEW FOR THE PREVENTION OF ALZHEIMER'S DISEASE
    Valenzuela B, Rodrigo
    Bascunan G, Karla
    Valenzuela B, Alfonso
    REVISTA CHILENA DE NUTRICION, 2008, 35 : 250 - 261
  • [2] Effects of docosahexaenoic acid (DHA) in slowing the progression of Alzheimer's disease
    Quinn, Joseph
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S54 - S55
  • [3] DOCOSAHEXAENOIC ACID: ALZHEIMER'S DISEASE PREVENTION AND TREATMENT
    不详
    GERONTOLOGIST, 2008, 48 : 263 - 263
  • [4] Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study -Sponsored DHA Clinical Trial
    Tomaszewski, Natalie
    He, Xulei
    Solomon, Victoria
    Lee, Mitchell
    Mack, Wendy J.
    Quinn, Joseph F.
    Braskie, Meredith N.
    Yassine, Hussein N.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (03) : 975 - 990
  • [5] Docosahexaenoic acid (DHA) in stroke, Alzheimer's disease, and blinding retinal degenerations: coping with neuroinflammation and sustaining cell survival
    Bazan, Nicolas G.
    Asatryan, Aram
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2011, 18 (04) : 208 - 213
  • [6] Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer's Disease
    Zussy, Charleine
    John, Rijo
    Urgin, Theo
    Otaegui, Lea
    Vigor, Claire
    Acar, Niyazi
    Canet, Geoffrey
    Vitalis, Mathieu
    Morin, Francoise
    Planel, Emmanuel
    Oger, Camille
    Durand, Thierry
    Rajshree, Shinde L.
    Givalois, Laurent
    Devarajan, Padma V.
    Desrumaux, Catherine
    ANTIOXIDANTS, 2022, 11 (05)
  • [8] Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?
    Pomponi, Massimo F. L.
    Gambassi, Giovanni
    Pomponi, Massimiliano
    Di Gioia, Annamaria
    Masullo, Carlo
    AGEING RESEARCH REVIEWS, 2011, 10 (01) : 124 - 131
  • [9] The hydroxylated form of docosahexaenoic acid (DHA-H) modifies the brain lipid composition in a model of Alzheimer's disease, improving behavioral motor function and survival
    Mohaibes, Raheem J.
    Fiol-deRoque, Maria A.
    Torres, Manuel
    Ordinas, Margarita
    Lopez, David J.
    Castro, Jose A.
    Escriba, Pablo V.
    Busquets, Xavier
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2017, 1859 (09): : 1596 - 1603
  • [10] Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer's Disease
    Anoush, Mahdieh
    Pourmansouri, Zeinab
    Javadi, Rafi
    GhorbanPour, Benyamin
    Shara, Ali
    Mohamadpour, Hamed
    Anarkooli, Iraj jafari
    Andalib, Sina
    ACS OMEGA, 2022, 7 (16): : 13861 - 13869